Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).

The waxy fraction from the variety Carma of fiber hemp (Cannabis sativa) afforded the unusual cannabinoid 4, identified as the farnesyl prenylogue of cannabigerol (CBG, 1) on the basis of its spectroscopic properties. A comparative study of the profile of 4 and 1 toward metabotropic (CB1, CB2) and ionotropic (TRPV1, TRPV2, TRPM8, TRPA1) targets of phytocannabinoids showed that prenylogation increased potency toward CB2 by ca. 5-fold, with no substantial difference toward the other end-points, except for a decreased affinity for TRPM8. The isolation of 4 suggests that C. sativa could contain yet-to-be-discovered prenylogous versions of medicinally relevant cannabinoids, for which their biological profiles could offer interesting opportunities for biomedical exploitation.

[1]  Georg Krupitza,et al.  Ferruginenes A-C from Rhododendron ferrugineum and their cytotoxic evaluation. , 2011, Journal of natural products.

[2]  G. Appendino,et al.  Cannabioxepane, a Novel Tetracyclic Cannabinoid from Hemp, Cannabis sativa L. , 2011 .

[3]  F. Bohlmann,et al.  Cannabigerol-ähnliche verbindungen aus Helichrysum umbraculigerum☆ , 1979 .

[4]  Zhongxin Lu,et al.  Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro , 2005, FEBS letters.

[5]  T. Bisogno,et al.  Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes , 2011, British journal of pharmacology.

[6]  Kirsten Jørgensen,et al.  Metabolon formation and metabolic channeling in the biosynthesis of plant natural products. , 2005, Current opinion in plant biology.

[7]  T. Goto,et al.  The structure of grifolin, an antibiotic from a basidiomycete. , 1963, Tetrahedron.

[8]  S. Morimoto,et al.  First direct evidence for the mechanism of .DELTA.1-tetrahydrocannabinolic acid biosynthesis , 1995 .

[9]  R. Capasso,et al.  Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. , 2009, Trends in pharmacological sciences.

[10]  Michael Stavri,et al.  Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. , 2008, Journal of natural products.

[11]  G. Appendino,et al.  Cannabinoids: occurrence and medicinal chemistry. , 2011, Current medicinal chemistry.

[12]  F. J. Caballero,et al.  Denbinobin, a naturally occurring 1,4-phenanthrenequinone, inhibits HIV-1 replication through an NF-kappaB-dependent pathway. , 2008, Biochemical pharmacology.

[13]  C. Walsh.  The chemical versatility of natural-product assembly lines. , 2008, Accounts of chemical research.

[14]  K. Lee,et al.  Isolation of rhododaurichromanic acid B and the anti-HIV principles rhododaurichromanic acid A and rhododaurichromenic acid from Rhododendron dauricum , 2001 .

[15]  Y. Choi,et al.  NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa. , 2004, Phytochemical analysis : PCA.

[16]  M. Maffei,et al.  A Polar Cannabinoid from Cannabis Sativa Var. Carma , 2008 .

[17]  L. Petrocellis,et al.  Cannabimovone, a Cannabinoid with a Rearranged Terpenoid Skeleton from Hemp , 2010 .